12 responses to “When vulvovaginal atrophy involves loss of genital sexual sensitivity: local (vaginal) dehydroepiandrosterone (DHEA) shows promise”

  1. Interesting but not mainstream yet. Still this seems safe and worth a try.

  2. i would want to read more about potential risk involve and length of trail that was done to evaluate the safety of this treatment.

  3. I have few patients to try this approach – will definitely read more

  4. Heard Dr.Basson talk about this at a St.Paul’s meeting 2 years ago.
    Came back to my small Vancouver Island community and asked one of my pharmacists to compound these up only to be told that DHEA is a controlled substance under Olympic anti-doping rules and she could not get it.
    Had to go to a Vancouver Pharmacist

  5. Good to know this.

  6. good to know this

  7. A good reminder to ask, and not to assume. Nice article Rosemary.

  8. I wonder if a large episiotomy &/or deep vaginal-perineal tears during childbirth can damage the sensory nerves en route to the clitoris, and thereby reduce sexual stimulation/arounsal/responsiveness. I would be interested in Dr. Basson’s opinion on this question. Thank you.

  9. Interesting article. It would be far more practical if Dr. Basson gave the specific formulation of DHEAS she has found beneficial.

  10. I am wondering how this would be for breast cancer survivors. Does anyone know?

  11. I have a patient who has told me that she just doesn’t feel the same in the genitals, and that her orgasms didn’t feel the same, and I thought it was psychological. I will be happy to talk to her about this.

  12. Interesting to read this article, I have a patient I put on Menopause Hormone replacement therapy recently who on review reported improvement in Vasomotor symptoms but was quite distressed about her continued loss of libido.
    This is something I may recommend to her.
    What regime or specifically how will you advise writing the prescription for the intravaginal DHEA?Dosing ,Duration etc

Leave a Reply